Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?

× No keyword cloud information.

4 in total

1. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Authors: B M Psaty; N S Weiss; C D Furberg; T D Koepsell; D S Siscovick; F R Rosendaal; N L Smith; S R Heckbert; R C Kaplan; D Lin; T R Fleming; E H Wagner
Journal: JAMA Date: 1999-08-25 Impact factor: 56.272

2. Biomarkers and surrogate endpoints in clinical trials.

Authors: Thomas R Fleming; John H Powers
Journal: Stat Med Date: 2012-06-18 Impact factor: 2.373

3. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

Authors: Steven E Nissen; Neville D Yeomans; Daniel H Solomon; Thomas F Lüscher; Peter Libby; M Elaine Husni; David Y Graham; Jeffrey S Borer; Lisa M Wisniewski; Katherine E Wolski; Qiuqing Wang; Venu Menon; Frank Ruschitzka; Michael Gaffney; Bruce Beckerman; Manuela F Berger; Weihang Bao; A Michael Lincoff
Journal: N Engl J Med Date: 2016-11-13 Impact factor: 91.245

Review 4. Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

Authors: Sean L Zheng; Alistair J Roddick; Rochan Aghar-Jaffar; Matthew J Shun-Shin; Darrel Francis; Nick Oliver; Karim Meeran
Journal: JAMA Date: 2018-04-17 Impact factor: 56.272

4 in total